Evidence map›Paper›PMID 31852511›Full record

ArticleBMC pharmacology & toxicology2019

Melatonin-loaded lipid-core nanocapsules protect against lipid peroxidation caused by paraquat through increased SOD expression in Caenorhabditis elegans.

Mariele F Charão, Gabriela Goethel, Natália Brucker, Karina Paese, Vera L Eifler-Lima, Adriana R Pohlmann, Silvia S Guterres, Solange C Garcia

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Effects of melatonin on protecting against lung injury (Review).Experimental and therapeutic medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mariele F CharãoLaboratory of Toxicology (LATOX), Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, Rio Grande do Sul, Brazil.
Gabriela GoethelLaboratory of Toxicology (LATOX), Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, Rio Grande do Sul, Brazil.
Natália BruckerLaboratory of Toxicology (LATOX), Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, Rio Grande do Sul, Brazil.
Karina PaesePost-graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, RS, Brazil.
Vera L Eifler-LimaPost-graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, RS, Brazil.
Adriana R PohlmannPost-graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, RS, Brazil.
Silvia S GuterresPost-graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, RS, Brazil.
Solange C GarciaLaboratory of Toxicology (LATOX), Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Porto Alegre, Rio Grande do Sul, Brazil. solange.garcia@ufrgs.br.
Universidade Federal do Rio Grande do Sul · BRUniversidade Feevale · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelatonin has been described in the literature as a potent antioxidant. However, melatonin presents variable, low bioavailability and a short half-life. The use of polymeric nanoparticulated systems has been proposed for controlled release. Thus, the purpose of this study was to investigate the action of melatonin-loaded lipid-core nanocapsules (Mel-LNC) in the antioxidant system of Caenorhabditis elegans, and the possible protective effect of this formulation against lipid peroxidation caused by paraquat (PQ).

methodsThe suspensions were prepared by interfacial deposition of the polymer and were physiochemically characterized. C. elegans N2 wild type and transgenic worm CF1553, muls84 [sod-3p::gfp; rol6(su1006)] were obtained from the Caenorhabditis Genetics Center (CGC). The worms were divided into 5 groups: Control, PQ 0.5 mM, PQ 0.5 mM + Mel-LNC 10 μg/mL, PQ + unloaded lipid-core nanocapsules (LNC), and PQ + free melatonin (Mel) 10 μg/mL. The lipid peroxidation was assessed through thiobarbituric acid (TBARS) levels and the fluorescence levels of the transgenic worms expressing GFP were measured.

resultsThe LNC and Mel-LNC presented a bluish-white liquid, with pH values of 5.56 and 5.69, respectively. The zeta potential was - 6.4 ± 0.6 and - 5.2 ± 0.2, respectively. The mean particle diameter was 205 ± 4 nm and 203 ± 3 nm, respectively. The total melatonin content was 0.967 mg/ml. The TBARS levels were significantly higher in the PQ group when compared to the control group (p < 0.001). Mel-LNC reduced TBARS levels to similar levels found in the control group. Moreover, only Mel-LNC significantly enhanced the SOD-3 expression (p < 0.05). Mel-LNC was capable of protecting C. elegans from lipid peroxidation caused by PQ and this was not observed when free melatonin was used. Moreover, Mel-LNC increased the fluorescence intensity of the transgenic strain that encodes the antioxidant enzyme SOD-3, demonstrating a possible mechanism of protection from PQ-induced damage.

conclusionThese findings demonstrated that melatonin, when associated with nanocapsules, had improved antioxidant properties and the protective activity against PQ-induced lipid peroxidation could be associated with the activation of antioxidant enzymes by Mel-LNC in C. elegans.

Indexed as

AnimalsAntioxidantsCaenorhabditis elegansDrug CarriersDrug CompoundingLipid PeroxidationLipidsMelatoninNanocapsulesParaquatParticle SizeSuperoxide DismutaseAntioxidantsDrug CarriersLipidsMelatoninNanocapsulesParaquatSuperoxide DismutaseAntioxidantC. elegansHerbicideNanocapsulesSuperoxide dismutase

Identifiers

PMID31852511
PMCPMC6921496
OpenAlexW2995800778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.